BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26893402)

  • 1. EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study.
    Malapelle U; de Luca C; Vigliar E; Ambrosio F; Rocco D; Pisapia P; Bellevicine C; Troncone G
    J Clin Pathol; 2016 May; 69(5):454-7. PubMed ID: 26893402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct sequencing in cytological specimens as a useful strategy for detecting EGFR mutations in non-small cell lung cancer patients.
    Cho MC; Choi CM; Kim S; Jang S; Jang S; Park CJ; Chi HS; Peyton MJ; Lee W; Chun S; Kim SW; Min WK
    Clin Chem Lab Med; 2011 Sep; 50(3):565-72. PubMed ID: 21899495
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    De Luca C; Gragnano G; Pisapia P; Vigliar E; Malapelle U; Bellevicine C; Troncone G
    J Clin Pathol; 2017 Apr; 70(4):295-300. PubMed ID: 27543600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel method for detection of mutation in epidermal growth factor receptor.
    Zhao J; Zhao J; Huang J; Chen Y; Jiang J; Wu W; Wang P; Liu L; Li L; Wu L; Wang M; Chen W
    Lung Cancer; 2011 Nov; 74(2):226-32. PubMed ID: 21439672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients.
    Malapelle U; Bellevicine C; De Luca C; Salatiello M; De Stefano A; Rocco D; de Rosa N; Vitiello F; Russo S; Pepe F; Iaccarino A; Micheli P; Illiano A; Carlomagno C; Piantedosi FV; Troncone G
    Cancer Cytopathol; 2013 Oct; 121(10):552-60. PubMed ID: 23780873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
    Xu H; Sun W; Zhang G; Cheng Y
    J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay.
    Endo K; Konishi A; Sasaki H; Takada M; Tanaka H; Okumura M; Kawahara M; Sugiura H; Kuwabara Y; Fukai I; Matsumura A; Yano M; Kobayashi Y; Mizuno K; Haneda H; Suzuki E; Iuchi K; Fujii Y
    Lung Cancer; 2005 Dec; 50(3):375-84. PubMed ID: 16199108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer.
    Masago K; Fujita S; Hata A; Okuda C; Yoshizumi Y; Kaji R; Katakami N; Hirata Y; Yatabe Y
    Pathol Int; 2018 Mar; 68(3):167-173. PubMed ID: 29341374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients.
    Zhao X; Han RB; Zhao J; Wang J; Yang F; Zhong W; Zhang L; Li LY; Wang MZ
    Respiration; 2013; 85(2):119-25. PubMed ID: 22797485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.
    Molina-Vila MA; Bertran-Alamillo J; Reguart N; Taron M; Castellà E; Llatjós M; Costa C; Mayo C; Pradas A; Queralt C; Botia M; Pérez-Cano M; Carrasco E; Tomàs M; Mate JL; Moran T; Rosell R
    J Thorac Oncol; 2008 Nov; 3(11):1224-35. PubMed ID: 18978556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of EGFR-TK domain-activating mutations in NSCLC with generic PCR-based methods.
    Shahi RB; De Brakeleer S; De Grève J; Geers C; In't Veld P; Teugels E
    Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):163-71. PubMed ID: 25751592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
    Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M
    Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction.
    Oskina N; Oscorbin I; Khrapov E; Boyarskikh U; Subbotin D; Demidova I; Imyanitov E; Filipenko M
    Mol Diagn Ther; 2017 Oct; 21(5):555-562. PubMed ID: 28589341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of EGFR gene mutations using the wash fluid of CT-guided biopsy needle in NSCLC patients.
    Otani H; Toyooka S; Soh J; Yamamoto H; Suehisa H; Kobayashi N; Gobara H; Mimura H; Kiura K; Sano Y; Kanazawa S; Date H
    J Thorac Oncol; 2008 May; 3(5):472-6. PubMed ID: 18448998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.
    Fukui T; Ohe Y; Tsuta K; Furuta K; Sakamoto H; Takano T; Nokihara H; Yamamoto N; Sekine I; Kunitoh H; Asamura H; Tsuchida T; Kaneko M; Kusumoto M; Yamamoto S; Yoshida T; Tamura T
    Clin Cancer Res; 2008 Aug; 14(15):4751-7. PubMed ID: 18676744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.
    Cushman-Vokoun AM; Crowley AM; Rapp SA; Greiner TC
    Am J Clin Pathol; 2013 Jul; 140(1):7-19. PubMed ID: 23765529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis.
    Nomoto K; Tsuta K; Takano T; Fukui T; Fukui T; Yokozawa K; Sakamoto H; Yoshida T; Maeshima AM; Shibata T; Furuta K; Ohe Y; Matsuno Y
    Am J Clin Pathol; 2006 Oct; 126(4):608-15. PubMed ID: 16938658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples.
    Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T
    Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients.
    Yung TK; Chan KC; Mok TS; Tong J; To KF; Lo YM
    Clin Cancer Res; 2009 Mar; 15(6):2076-84. PubMed ID: 19276259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer.
    Takata M; Chikumi H; Matsunami K; Kodani M; Sakamoto T; Hashimoto K; Nakamoto M; Okada K; Kitaura T; Matsumoto S; Kurai J; Yamasaki A; Igishi T; Burioka N; Shimizu E
    Oncol Rep; 2015 Mar; 33(3):1040-8. PubMed ID: 25591975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.